Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study
- PMID: 25521746
- PMCID: PMC4416963
- DOI: 10.1001/jamaophthalmol.2014.5185
Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study
Abstract
Importance: Detection of treatment-requiring retinopathy of prematurity (ROP) involves serial eye examinations. An ROP prediction model using predictive factors could identify high-risk infants and reduce required eye examinations.
Objective: To determine predictive factors for the development of referral-warranted (RW) ROP.
Design, setting, and participants: This multicenter observational cohort study included secondary analysis of data from the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity Study. Infants included in the study had a birth weight (BW) of less than 1251 g.
Exposures: Serial ROP examinations of premature infants who had 2 or more ROP examinations.
Main outcomes and measures: Incidence of RW-ROP (defined as the presence of plus disease, zone I ROP, or ROP stage 3 or greater in either eye) and associations with predictive factors.
Results: Among 979 infants without RW-ROP at first study-related eye examination (median postmenstrual age, 33 weeks; range, 29-40 weeks) who underwent at least 2 eye examinations, 149 (15.2%) developed RW-ROP. In a multivariate model, significant predictors for RW-ROP were male sex (odds ratio [OR], 1.80; 95% CI, 1.13-2.86 vs female), nonblack race (OR, 2.76; 95% CI, 1.50-5.08 for white vs black race and OR, 4.81; 95% CI, 2.19-10.6 for other vs black race), low BW (OR, 5.16; 95% CI, 1.12-7.20 for ≤500 g vs >1100 g), younger gestational age (OR, 9.79; 95% CI, 3.49-27.5 for ≤24 weeks vs ≥28 weeks), number of quadrants with preplus disease (OR, 7.12; 95% CI, 2.53-20.1 for 1-2 quadrants and OR, 18.4; 95% CI, 4.28-79.4 for 3-4 quadrants vs no preplus disease), stage 2 ROP (OR, 4.13; 95% CI, 2.13-8.00 vs no ROP), the presence of retinal hemorrhage (OR, 4.36; 95% CI, 1.57-12.1 vs absence), the need for respiratory support (OR, 4.99; 95% CI, 1.89-13.2 for the need for controlled mechanical ventilator; OR, 11.0; 95% CI, 2.26-53.8 for the need for high-frequency oscillatory ventilation vs no respiratory support), and slow weight gain (OR, 2.44; 95% CI, 1.22-4.89 for weight gain ≤12 g/d vs >18 g/d). These characteristics predicted the development of RW-ROP significantly better than BW and gestational age (area under receiver operating characteristic curve, 0.88 vs 0.78; P < .001).
Conclusions and relevance: When controlling for very low BW and prematurity, the presence of preplus disease, stage 2 ROP, retinal hemorrhage, and the need for ventilation at time of first study-related eye examination were strong independent predictors for RW-ROP. These predictors may help identify infants in need of timely eye examinations.
Conflict of interest statement
Figures
Comment in
-
Predictors for referral-warranted retinopathy of prematurity.Acta Paediatr. 2017 Jun;106(6):1013. doi: 10.1111/apa.13740. Epub 2017 Jan 30. Acta Paediatr. 2017. PMID: 28134457 No abstract available.
Similar articles
-
Plus Disease in Telemedicine Approaches to Evaluating Acute-Phase ROP (e-ROP) Study: Characteristics, Predictors, and Accuracy of Image Grading.Ophthalmology. 2019 Jun;126(6):868-875. doi: 10.1016/j.ophtha.2019.01.021. Epub 2019 Jan 25. Ophthalmology. 2019. PMID: 30690127
-
Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study.Ophthalmology. 2016 Oct;123(10):2176-82. doi: 10.1016/j.ophtha.2016.06.037. Epub 2016 Aug 2. Ophthalmology. 2016. PMID: 27491396 Free PMC article.
-
Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.Ophthalmology. 2017 Mar;124(3):374-381. doi: 10.1016/j.ophtha.2016.10.040. Epub 2016 Dec 13. Ophthalmology. 2017. PMID: 27986386 Free PMC article.
-
[Retinopathy of prematurity--risk factors].Harefuah. 2002 Dec;141(12):1066-9, 1089. Harefuah. 2002. PMID: 12534206 Review. Hebrew.
-
International Classification of Retinopathy of Prematurity, Third Edition.Ophthalmology. 2021 Oct;128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031. Epub 2021 Jul 8. Ophthalmology. 2021. PMID: 34247850 Review.
Cited by
-
Oxygenation Fluctuations Associated with Severe Retinopathy of Prematurity: Insights from a Multimodal Deep Learning Approach.Ophthalmol Sci. 2023 Oct 21;4(2):100417. doi: 10.1016/j.xops.2023.100417. eCollection 2024 Mar-Apr. Ophthalmol Sci. 2023. PMID: 38059124 Free PMC article.
-
Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity.Front Pharmacol. 2023 May 30;14:1165356. doi: 10.3389/fphar.2023.1165356. eCollection 2023. Front Pharmacol. 2023. PMID: 37324456 Free PMC article.
-
Retinopathy of prematurity: risk stratification by gestational age.J Perinatol. 2023 Jun;43(6):694-701. doi: 10.1038/s41372-023-01604-9. Epub 2023 Jan 18. J Perinatol. 2023. PMID: 36653668
-
Racial Differences in Retinopathy of Prematurity.Ophthalmic Epidemiol. 2023 Oct;30(5):523-531. doi: 10.1080/09286586.2023.2168014. Epub 2023 Jan 16. Ophthalmic Epidemiol. 2023. PMID: 36647265
-
Pediatric Eye Evaluations Preferred Practice Pattern.Ophthalmology. 2023 Mar;130(3):P222-P270. doi: 10.1016/j.ophtha.2022.10.030. Epub 2022 Dec 19. Ophthalmology. 2023. PMID: 36543602 Free PMC article. No abstract available.
References
-
- Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77–82. - PubMed
-
- Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106(4):471–479. - PubMed
-
- Good WV, Hardy RJ Early Treatment for Retinopathy of Prematurity Cooperative Group. The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP) Ophthalmology. 2001;108(6):1013–1014. - PubMed
-
- Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch Ophthalmol. 2003;121(12):1684–1694. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
